Leave Your Message
Explore our premium selection of medical-grade raw materials designed to work in synergy with Vitamin K2 MK7 for optimal therapeutic efficacy.
In the rapidly evolving landscape of preventive medicine and clinical nutrition, Vitamin K2 MK7 (Menaquinone-7) Powder has emerged as a cornerstone bioactive compound. Unlike its historical predecessor Vitamin K1 (phylloquinone), which primarily regulates blood coagulation in the liver, Vitamin K2 MK7 serves as a systemic driver of calcium utilization. For the pharmaceutical and healthcare sectors, this represents a revolutionary therapeutic agent capable of addressing two of the most prevalent chronic conditions associated with aging: osteoporosis and cardiovascular disease.
The "calcium paradox"—where a lack of calcium in the bones coexists with a pathological excess of calcium in the arteries—is a major clinical challenge. Vitamin K2 MK7 directly resolves this paradox by activating specific proteins that guide calcium out of the bloodstream and into the skeletal matrix. As clinical evidence continues to mount, the global demand for high-purity Vitamin K2 MK7 powder has surged, establishing it as an essential active pharmaceutical ingredient (API) and key nutraceutical component.
While Vitamin K2 exists in several forms (known as menaquinones, ranging from MK4 to MK13), the MK7 isomer stands out due to its superior bioavailability and prolonged half-life. While Vitamin K1 and Vitamin K2 MK4 disappear from the circulation within hours, MK7 remains active in the blood for up to 72 hours. This extended presence ensures consistent, round-the-clock activation of extrahepatic vitamin K-dependent proteins, allowing for significantly lower and more effective daily dosages.
The industrial landscape for Vitamin K2 MK7 is undergoing a profound transformation. Historically viewed as a niche dietary supplement ingredient, it is now rapidly transitioning into mainstream pharmaceutical formulations, clinical foods, and fortifying agents. According to recent market analyses, the global Vitamin K2 market is projected to grow at a CAGR of over 14% through the next decade, with the pharmaceutical and healthcare sectors representing the fastest-growing segments.
This growth is driven by several key factors:
The manufacturing of pharmaceutical-grade Vitamin K2 MK7 powder requires exceptional chemical precision and biotechnological control. YTBIO utilizes advanced natural bio-fermentation processes, leveraging non-GMO strains of Bacillus subtilis natto. This biological pathway yields the highly bioactive all-trans isomer of MK7, which is the only form recognized and utilized by the human body. The cis-isomers, often found in low-quality synthetic alternatives, are biologically inactive and offer no therapeutic value.
Furthermore, because Vitamin K2 is highly sensitive to environmental factors such as light, moisture, and alkaline conditions, advanced stabilization is critical. For pharmaceutical applications, we offer microencapsulated, starch-coated, and oil-suspended formulations that shield the MK7 molecules from degradation, ensuring a long shelf-life and compatibility with multi-ingredient formulations (such as calcium carbonate or magnesium complexes).
Osteoporosis is characterized by a systemic decline in bone mineral density (BMD) and microarchitectural deterioration of bone tissue. The biological mechanism of Vitamin K2 MK7 in mitigating this condition revolves around the activation of Osteocalcin, a protein synthesized by osteoblasts. Osteocalcin is responsible for binding ionic calcium to the hydroxyapatite crystal matrix of the bone. In its inactive (undercarboxylated) state, osteocalcin cannot bind calcium, leaving bones weak and porous. Vitamin K2 acts as an essential co-factor for the gamma-glutamyl carboxylase enzyme, transforming undercarboxylated osteocalcin into its active, bone-building form.
Arterial calcification is an independent risk factor for cardiovascular events, including myocardial infarction and stroke. Within the vascular wall, Vitamin K2 MK7 activates Matrix Gla Protein (MGP), a potent local inhibitor of calcification. Once carboxylated by Vitamin K2, MGP binds to calcium crystals in the blood vessels and prevents them from depositing in the arterial intima and media. Clinical trials have demonstrated that regular intake of Menaquinone-7 significantly reduces arterial stiffness, improves arterial elasticity, and lowers the risk of coronary heart disease.
Patients suffering from Chronic Kidney Disease are particularly susceptible to accelerated vascular calcification due to disrupted calcium-phosphate homeostasis. This condition, often referred to as calciphylaxis, contributes to extremely high mortality rates in dialysis patients. Pharmaceutical-grade Vitamin K2 MK7 powder is currently under intense clinical study as a therapeutic intervention to slow down or halt arterial calcification in CKD patients, offering a new pathway for renal-cardiovascular protection.
As healthcare trends shift toward personalized medicine, the delivery systems for Vitamin K2 MK7 are becoming more sophisticated. Future developments are focused on nano-emulsions for enhanced liquid absorption, clean-label organic carrier powders, and combination therapies targeting metabolic syndrome and joint health. By combining high-purity Vitamin K2 MK7 with other essential minerals and botanical extracts, pharmaceutical developers can create highly targeted, synergistic therapies that address the complex, multi-factorial nature of age-related degeneration.
Backed by state-of-the-art facilities and a dedicated scientific team, we deliver industry-leading quality standards for global distribution.
We provide versatile processing solutions to transform raw Vitamin K2 MK7 powder into ready-to-market consumer products.
Nutritional supplement raw materials are mainly used in the fields of medicine, health products, etc. to supplement the amino acids, trace elements, vitamins, minerals, etc. required by the human body. YTBIO has ten years of experience in the raw materials industry and has sufficient understanding of the industry and products. Now we support OEM/ODM services. Through continuous innovation and persistence in quality, we are committed to providing reliable health products to global customers and promoting the sustainable development of the health industry.
See More
The capsule categories we provide are: hard capsules, soft capsules, and pellet capsules. About customization: ingredients, packaging, labels, etc. can all be customized. In addition, we focus on customized formulas, and a variety of existing formulas and stocks are waiting for you to choose. The production facilities and equipment meet national standards, and the production process is strictly carried out in accordance with GMP requirements.
See More
Technologies include boiling granulation, direct tablet compression of all powders, semi-film coating, new excipients, new processes and production linkage, etc. The production materials meet national standards, undergo comprehensive inspection and quality control, and the production process is strictly carried out in accordance with scientific production process. About customization: ingredients, shape, packaging, labeling, etc. In addition, there are many formulas and stocks for you to choose from.
See More
Since its establishment in 2014, Shaanxi Yuantai Biological Technology Co., Ltd. has always focused on the research, development, production and sales of herbal extracts, nutritional supplements, organic products and OEM/ODM services. With high standards of product quality and a professional team as the core, the company provides customers with high-quality health product solutions. It always adheres to the concept of sustainability, balance and health to ensure that the products meet market demand and consumer expectations.
Learn More
All YTBIO products are produced by ourselves, covering an area of 10000+ square meters, with advanced extraction equipment and mature extraction technology. In addition, we have also set up separate production areas for capsules, granules, tablets, solid beverages, etc.
The production facilities and equipment meet national standards, and the production process is strictly carried out in accordance with GMP requirements. And constantly update QA/QC standards to enhance the core competitiveness in quality control and R&D levels.
The certificates currently obtained include cGMP, FSSC22000, BRC, HACCP, ISO9001, ISO22000, HALAL, KOSHER, FDA, organic and other certificates.
Provide customers with quality products. For product information and quotes, contact us!
Contact UsYTBIO covers an area of 10000+㎡ and has passed cGMP, FSSC22000, BRC, ISO9001, ISO22000, KOSHER, HALAL, FDA, and organic certifications. The production process is strictly carried out in accordance with scientific production process to ensure the safety, stability and effectiveness of the products.
Discover our comprehensive portfolio of high-purity vitamins, botanical extracts, and mineral formulations.
